Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

951
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
951
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

395
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
395
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

1.0K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

360
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
360

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stress-Induced (Takotsubo) Cardiomyopathy Associated With Upadacitinib Induction Therapy in Severe Crohn's Disease.

ACG case reports journal·2026
Same author

Racial and Ethnic Disparities in the Management and Outcomes of Acute Myocardial Infarction Complicated by Ventricular Arrhythmias.

Journal of clinical medicine·2026
Same author

Recovery of a Broken Snare in Coronary Intervention.

JACC. Case reports·2026
Same author

Comparison of clinical outcomes of acute myocardial infarction patients complicated with cardiogenic shock treated with intra-aortic balloon pump versus microaxial flow pump.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same author

Intravascular Lithotripsy of Negatively Remodeled Calcified Abdominal Aorta to Facilitate Transfemoral Transcatheter Aortic Valve Replacement.

JACC. Case reports·2026
Same author

Threading a needle: percutaneous closure of an incompletely ligated left atrial appendage.

Future cardiology·2025

Related Experiment Video

Updated: Feb 11, 2026

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.2K

Palliative Care in Heart Failure.

Abhinav Sood1, Krista Dobbie2, W H Wilson Tang1

  • 1, Cleveland, USA.

Current Treatment Options in Cardiovascular Medicine
|April 20, 2018
PubMed
Summary

Palliative care improves quality of life for heart failure patients by managing symptoms and addressing emotional well-being. Early integration of palliative care enhances patient outcomes without hindering standard heart failure treatments.

Keywords:
Advanced heart failureGoals of careHeart failurePalliative care

More Related Videos

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

2.0K
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
07:35

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

13.4K

Related Experiment Videos

Last Updated: Feb 11, 2026

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.2K
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

2.0K
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
07:35

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

13.4K

Area of Science:

  • Cardiology
  • Palliative Medicine
  • Symptom Management

Background:

  • Heart failure (HF) is a chronic condition requiring comprehensive management.
  • Symptom burden significantly impacts quality of life in HF patients.
  • Palliative care offers specialized support for symptom management and patient well-being.

Purpose of the Study:

  • To review the role of palliative care in heart failure (HF) management.
  • To summarize pharmacologic and non-pharmacologic symptom palliation strategies for HF.
  • To discuss common patient care issues at the intersection of HF and palliative medicine.

Main Methods:

  • Literature review of palliative care in heart failure.
  • Synthesis of pharmacologic and non-pharmacologic interventions.
  • Discussion of clinical experiences and patient care challenges.

Main Results:

  • Integrating palliative care improves quality of life, reduces anxiety and depression, and enhances spiritual well-being in HF patients.
  • Palliative care is distinct from hospice care and should be involved early.
  • Early palliative care involvement aids symptom palliation, goal-of-care discussions, and quality of life improvement without compromising evidence-based HF therapies.

Conclusions:

  • Palliative care plays a vital role in optimizing heart failure management.
  • Early integration of palliative care strategies is beneficial for symptom control and patient well-being.
  • Further consensus is needed on optimal timing and evidence for specific palliative interventions in HF.